Sumoylation of the astroglial glutamate transporter EAAT2 governs its intracellular compartmentalization

GLIA

Volumn 62, Issue 8, 2014, Pages 1241-1253

  Foran, E ^a   Rosenblum, L ^a   Bogush, A ^a   Pasinelli, P ^a   Trotti, D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Excitotoxicity; GLT 1; Protein trafficking

Indexed keywords

CASPASE 3; COPPER ZINC SUPEROXIDE DISMUTASE; EXCITATORY AMINO ACID TRANSPORTER 2; PROTEIN UBC9; SUMO 1 PROTEIN; CASP3 PROTEIN, RAT; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; SLC1A2 PROTEIN, HUMAN; SLC1A2 PROTEIN, MOUSE; SLC1A2 PROTEIN, RAT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONJUGATION; CONTROLLED STUDY; DISEASE COURSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SPINAL CORD; SUMOYLATION; ANIMAL; CELL MEMBRANE; DISEASE MODEL; FOREBRAIN; GENETICS; HEK293 CELL LINE; HUMAN; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CASPASE 3; CELL MEMBRANE; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMATE PLASMA MEMBRANE TRANSPORT PROTEINS; GLUTAMIC ACID; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; MICE, TRANSGENIC; PROSENCEPHALON; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SUMOYLATION;

EID: 84902320440     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22677     Document Type: Article

References (52)

1. Benediktsson AM, Marrs GS, Tu JC, Worley PF, Rothstein JD, Bergles DE, Dailey ME. 2012. Neuronal activity regulates glutamate transporter dynamics in developing astrocytes. Glia 60:175-188.
2. Berry JD, Shefner JM, Conwit R, Schoenfeld D, Keroack M, Felsenstein D, Krivickas L, David WS, Vriesendorp F, Pestronk A, Caress JB, Katz J, Simpson E, Rosenfeld J, Pascuzzi R, Glass J, Rezania K, Rothstein JD, Greenblatt DJ, Cudkowicz ME. 2013. Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis. PLoS One 8:e61177.
3. Boillee S, Vande Velde C, Cleveland DW. 2006. ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52:39-59.
4. Boston-Howes W, Gibb SL, Williams EO, Pasinelli P, Brown RH Jr, Trotti D. 2006. Caspase-3 cleaves and inactivates the glutamate transporter EAAT2. J Biol Chem 281:14076-14084.
5. Bristol LA, Rothstein JD. 1996. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 39:676-679.
6. Butchbach ME, Tian G, Guo H, Lin CL. 2004. Association of excitatory amino acid transporters, especially EAAT2, with cholesterol-rich lipid raft microdomains: Importance for excitatory amino acid transporter localization and function. J Biol Chem 279:34388-34396.
7. Chaudhry FA, Lehre KP, van Lookeren Campagne M, Ottersen OP, Danbolt NC, Storm-Mathisen J. 1995. Glutamate transporters in glial plasma membranes: Highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15:711-720.
8. de la Vega L, Grishina I, Moreno R, Kruger M, Braun T, Schmitz ML. 2012. A redox-regulated SUMO/acetylation switch of HIPK2 controls the survival threshold to oxidative stress. Mol Cell 46:472-483.
9. Eng DL, Lee YL, Lal PG. 1997. Expression of glutamate uptake transporters after dibutyryl cyclic AMP differentiation and traumatic injury in cultured astrocytes. Brain Res 778:215-221.
10. Fei E, Jia N, Yan M, Ying Z, Sun Q, Wang H, Zhang T, Ma X, Ding H, Yao X, Shi Y, Wang G. 2006. SUMO-1 modification increases human SOD1 stability and aggregation. Biochem Biophys Res Commun 347:406-412.
11. Foran E, Bogush A, Goffredo M, Roncaglia P, Gustincich S, Pasinelli P, Trotti D. 2011. Motor neuron impairment mediated by a sumoylated fragment of the glial glutamate transporter EAAT2. Glia 59:1719-1731.
12. Foran E, Rosenblum L, Bogush AI, Trotti D. 2013. Sumoylation of critical proteins in amyotrophic lateral sclerosis: Emerging pathways of pathogenesis. Neuromol Med 15:760-770.
13. Foran E, Trotti D. 2009. Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid Redox Signal 11:1587-1602.
14. Furness DN, Dehnes Y, Akhtar AQ, Rossi DJ, Hamann M, Grutle NJ, Gundersen V, Holmseth S, Lehre KP, Ullensvang K, Wojewodzic M, Zhou Y, Attwell D, Danbolt NC. 2008. A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: New insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2). Neuroscience 157:80-94.
15. Gibb SL, Boston-Howes W, Lavina ZS, Gustincich S, Brown RH Jr, Pasinelli P, Trotti D. 2007. A caspase-3-cleaved fragment of the glial glutamate transporter EAAT2 is sumoylated and targeted to promyelocytic leukemia nuclear bodies in mutant SOD1-linked amyotrophic lateral sclerosis. J Biol Chem 282:32480-32490.
16. Guo H, Lai L, Butchbach ME, Stockinger MP, Shan X, Bishop GA, Lin CL. 2003. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum Mol Genet 12:2519-2532.
17. Gurney ME, Pu H, Chiu AY, Dal Canto M, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, Chen W, Zhai P, Sufit RL, Siddique T. 1994. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264:1772-1775.
18. Hickey CM, Wilson NR, Hochstrasser M. 2012. Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol 13:755-766.
19. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD. 2002. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 99:1604-1609.
20. Huang J, Yan J, Zhang J, Zhu S, Wang Y, Shi T, Zhu C, Chen C, Liu X, Cheng J, Mustelin T, Feng GS, Chen G, Yu J. 2012. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane. Nat Commun 3:911.
21. Ikematsu K, Tsuda R, Kondo T, Nakasono I. 2002. The expression of excitatory amino acid transporter 2 in traumatic brain injury. Forensic Sci Int 130:83-89.
22. Imasawa M, Kashiwagi K, Iizuka Y, Tanaka M, Tsukahara S. 2005. Different expression role among glutamate transporters in rat retinal glial cells under various culture conditions. Brain Res Mol Brain Res 142:1-8.
23. Jones MC, Fusi L, Higham JH, Abdel-Hafiz H, Horwitz KB, Lam EW, Brosens JJ. 2006. Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. Proc Natl Acad Sci U S A 103:16272-16277.
24. Kaikkonen S, Jaaskelainen T, Karvonen U, Rytinki MM, Makkonen H, Gioeli D, Paschal BM, Palvimo JJ. 2009. SUMO-specific protease 1 (SENP1) reverses the hormone-augmented SUMOylation of androgen receptor and modulates gene responses in prostate cancer cells. Mol Endocrinol 23:292-307.
25. Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB. 2011. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. J Cell Physiol 226:2484-2493.
26. Kondo K, Hashimoto H, Kitanaka J, Sawada M, Suzumura A, Marunouchi T, Baba A. 1995. Expression of glutamate transporters in cultured glial cells. Neurosci Lett 188:140-142.
27. Lee SG, Su ZZ, Emdad L, Gupta P, Sarkar D, Borjabad A, Volsky DJ, Fisher PB. 2008. Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes. J Biol Chem 283:13116-13123.
28. Leinenweber A, Machtens JP, Begemann B, Fahlke C. 2011. Regulation of glial glutamate transporters by C-terminal domains. J Biol Chem 286:1927-1937.
29. Loriol C, Khayachi A, Poupon G, Gwizdek C, Martin S. 2013. Activity-dependent regulation of the sumoylation machinery in rat hippocampal neurons. Biol Cell 105:30-45.
30. Martin S, Wilkinson KA, Nishimune A, Henley JM. 2007. Emerging extranuclear roles of protein SUMOylation in neuronal function and dysfunction. Nat Rev Neurosci 8:948-959.
31. Martinez-Villarreal J, Garcia Tardon N, Ibanez I, Gimenez C, Zafra F. 2012. Cell surface turnover of the glutamate transporter GLT-1 is mediated by ubiquitination/deubiquitination. Glia 60:1356-1365.
32. Melone M, Bellesi M, Ducati A, Iacoangeli M, Conti F. 2011. Cellular and synaptic localization of EAAT2a in human cerebral cortex. Front Neuroanat 4:151.
33. Miller MJ, Scalf M, Rytz TC, Hubler SL, Smith LM, Vierstra RD. 2013. Quantitative proteomics reveals factors regulating RNA biology as dynamic targets of stress-induced SUMOylation in Arabidopsis. Mol Cell Proteomics 12:449-463.
34. Mukherjee S, Thomas M, Dadgar N, Lieberman AP, Iniguez-Lluhi JA. 2009. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J Biol Chem 284:21296-21306.
35. Qian Y, Guan T, Tang X, Huang L, Huang M, Li Y, Sun H, Yu R, Zhang F. 2011. Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: An in vitro study of maslinic acid. Eur J Pharmacol 651:59-65.
36. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16:675-686.
37. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB. 2005. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73-77.
38. Sampson DA, Wang M, Matunis MJ. 2001. The small ubiquitin-like modifier-1 (SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-1 modification. J Biol Chem 276:21664-21669.
39. Sasaki S, Komori T, Iwata M. 2000. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis. Acta Neuropathol 100:138-144.
40. Schlag BD, Vondrasek JR, Munir M, Kalandadze A, Zelenaia OA, Rothstein JD, Robinson MB. 1998. Regulation of the glial Na+-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol Pharmacol 53:355-369.
41. Sharma P, Yamada S, Lualdi M, Dasso M, Kuehn MR. 2013. Senp1 is essential for desumoylating sumo1-modified proteins but dispensable for sumo2 and sumo3 deconjugation in the mouse embryo. Cell Rep 3:1640-1650.
42. Singh S, Pradhan AK, Chakraborty S. 2013. SUMO1 negatively regulates the transcriptional activity of EVI1 and significantly increases its co-localization with EVI1 after treatment with arsenic trioxide. Biochim Biophys Acta 1833:2357-2368.
43. Skytt DM, Madsen KK, Pajecka K, Schousboe A, Waagepetersen HS. 2010. Characterization of primary and secondary cultures of astrocytes prepared from mouse cerebral cortex. Neurochem Res 35:2043-2052.
44. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, Illes K, Lukacsovich T, Zhu YZ, Cattaneo E, and others. 2004. SUMO modification of Huntingtin and Huntington's disease pathology. Science 304:100-104.
45. Su YF, Yang T, Huang H, Liu LF, Hwang J. 2012. Phosphorylation of Ubc9 by Cdk1 enhances SUMOylation activity. PLoS One 7:e34250.
46. Swanson RA, Liu J, Miller JW, Rothstein JD, Farrell K, Stein BA, Longuemare MC. 1997. Neuronal regulation of glutamate transporter subtype expression in astrocytes. J Neurosci 17:932-940.
47. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M, Wada K. 1997. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276:1699-1702.
48. Trotti D, Peng JB, Dunlop J, Hediger MA. 2001. Inhibition of the glutamate transporter EAAC1 expressed in Xenopus oocytes by phorbol esters. Brain Res 914:196-203.
49. Wallis N, Zagami CJ, Beart PM, O'Shea RD. 2012. Combined excitotoxic-oxidative stress and the concept of non-cell autonomous pathology of ALS: Insights into motoneuron axonopathy and astrogliosis. Neurochem Int 61:523-530.
50. Watts FZ. 2013. Starting and stopping SUMOylation: What regulates the regulator? Chromosoma 122:451-463.
51. Wisman LA, van Muiswinkel FL, de Graan PN, Hol EM, Bar PR. 2003. Cells over-expressing EAAT2 protect motoneurons from excitotoxic death in vitro. Neuroreport 14:1967-1970.
52. Zagami CJ, O'Shea RD, Lau CL, Cheema SS, Beart PM. 2005. Regulation of glutamate transporters in astrocytes: Evidence for a relationship between transporter expression and astrocytic phenotype. Neurotox Res 7:143-149.